Both proteins have been suggested as potential biomarkers for the synapse loss in Alzheimer's disease,50-54 and decreasing levels of NPTXR in CSF has been shown to correspond with more severe Alzheimer's disease pathology.55 The gene discussed is NPTXR; the disease is early-onset autosomal dominant Alzheimer disease.